Article
Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Annals of neurology - 1 Dec 2016
Inzelberg Rivka, Flash Shira, Friedman Eitan, Azizi Esther
Abstract excerpt
The mechanisms underlying the high prevalence of cutaneous malignant melanoma (CMM) in Parkinson disease (PD) are unclear, but plausibly involve common pathways. 129Ser-phosphorylated α-synuclein, a pathological PD hallmark, is abundantly expressed in CMM, but not in normal skin. In inherited PD, PARK genes harbor germline mutations; the same genes are somatically mutated in CMM, or their encoded proteins are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
